These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 20175589)

  • 1. Outpatient medication costs of patients with cystic fibrosis in Germany.
    Eidt-Koch D; Wagner TO; Mittendorf T; Graf von der Schulenburg JM
    Appl Health Econ Health Policy; 2010; 8(2):111-8. PubMed ID: 20175589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cost of pharmacologic treatment and their determinants in ambulatory care of cystic fibrosis patients].
    Stelmach I; Korzeniewska A; Stelmach W
    Pneumonol Alergol Pol; 2004; 72(9-10):415-9. PubMed ID: 16021997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France.
    Horvais V; Touzet S; François S; Bourdy S; Bellon G; Colin C; Durieu I
    Int J Technol Assess Health Care; 2006; 22(4):525-31. PubMed ID: 16984688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resource usage in outpatient care and reimbursement for cystic fibrosis in Germany.
    Eidt-Koch D; Wagner TO; Mittendorf T; Reimann A; von der Schulenburg JM
    Pediatr Pulmonol; 2011 Mar; 46(3):278-85. PubMed ID: 24081887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of illness of cystic fibrosis in Germany: results from a large cystic fibrosis centre.
    Heimeshoff M; Hollmeyer H; Schreyögg J; Tiemann O; Staab D
    Pharmacoeconomics; 2012 Sep; 30(9):763-77. PubMed ID: 22690685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic management of cystic fibrosis.
    Kuhn RJ; Nahata MC
    Clin Pharm; 1985; 4(5):555-65. PubMed ID: 3931959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug treatment of cystic fibrosis - cost patterns and savings potential for outpatient treatment].
    Baltin CT; Smaczny C; Wagner TO
    Med Klin (Munich); 2010 Dec; 105(12):887-900. PubMed ID: 21240588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus.
    Heijerman H; Westerman E; Conway S; Touw D; Döring G;
    J Cyst Fibros; 2009 Sep; 8(5):295-315. PubMed ID: 19559658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of care and clinical condition in paediatric cystic fibrosis patients.
    Baumann U; Stocklossa C; Greiner W; von der Schulenburg JM; von der Hardt H
    J Cyst Fibros; 2003 Jun; 2(2):84-90. PubMed ID: 15463855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucolytics in cystic fibrosis.
    Henke MO; Ratjen F
    Paediatr Respir Rev; 2007 Mar; 8(1):24-9. PubMed ID: 17419975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.
    De Baets F; Schelstraete P; Van Daele S; Haerynck F; Vaneechoutte M
    J Cyst Fibros; 2007 Jan; 6(1):75-8. PubMed ID: 16793350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to treatment in children and adolescent patients with cystic fibrosis.
    Zindani GN; Streetman DD; Streetman DS; Nasr SZ
    J Adolesc Health; 2006 Jan; 38(1):13-7. PubMed ID: 16387243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging therapies in cystic fibrosis.
    Anderson P
    Ther Adv Respir Dis; 2010 Jun; 4(3):177-85. PubMed ID: 20530065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative assessment of inpatient and pulmonary drug costs for children with cystic fibrosis.
    Levy JF; Rosenberg MA; Farrell PM
    Pediatr Pulmonol; 2016 Dec; 51(12):1295-1303. PubMed ID: 27740724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of malnutrition in cystic fibrosis, and its treatment.
    Pencharz PB; Durie PR
    Clin Nutr; 2000 Dec; 19(6):387-94. PubMed ID: 11104588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic management of cystic fibrosis.
    Wallace CS; Hall M; Kuhn RJ
    Clin Pharm; 1993 Sep; 12(9):657-74; quiz 700-1. PubMed ID: 8306566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of airway inflammation in cystic fibrosis.
    Konstan MW
    Curr Opin Pulm Med; 1996 Nov; 2(6):452-6. PubMed ID: 9363184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health related quality of life in cystic fibrosis: To work or not to work?
    Havermans T; Colpaert K; Vanharen L; Dupont LJ
    J Cyst Fibros; 2009 May; 8(3):218-23. PubMed ID: 19328745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function.
    Padman R; McColley SA; Miller DP; Konstan MW; Morgan WJ; Schechter MS; Ren CL; Wagener JS;
    Pediatrics; 2007 Mar; 119(3):e531-7. PubMed ID: 17332172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung disease severity, chronic inflammation, iron deficiency, and erythropoietin response in adults with cystic fibrosis.
    Fischer R; Simmerlein R; Huber RM; Schiffl H; Lang SM
    Pediatr Pulmonol; 2007 Dec; 42(12):1193-7. PubMed ID: 17948283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.